NIH R01 · 2024
ABSTRACT Fibromyalgia (FM) is the quintessential nociplastic pain condition and is characterized by chronic widespread pain, mood and sleep disturbance, fatigue, and cognitive dysfunction, and affects >20 million Americans. Underserved individuals feel these impacts more profoundly as symptom burden is heavily influenced by social determinants of health (SDOH). As pharmacological treatments offer only small benefits and numerous adverse effects, guidelines suggest non-pharmacological treatments for FM such as physical therapy/exercise and cognitive behavioral therapy (CBT), although individuals with high SDOH risk have the least access and ability to consistently engage in these therapies.…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.